Urine test helps spot lung blood clots; Study: Companion Dx market slated to soar;

> Researchers have come up with a urine test that detects lung blood clots more accurately than existing blood tests. Story

> MDxHealth said its ConfirmMDx prostate cancer diagnostic test substantially reduced the repeat biopsy rate for patients in a successful new clinical utility study. Release

> Biomarkers exist that can be used to develop a diagnostic test for peripartum cardiomyopathy, a life-threatening disorder that kills pregnant women in developing countries, scientists have found. Release

> The CEO of MGC Diagnostics has resigned and will switch to a company that handles healthcare cost containment and wellness programs for small and midsize employers. Item

> The companion diagnostics market will grow in a big way over the next several years even in the face of low insurance reimbursement rates, the research and consulting firm GlobalData predicts. Release

> Activity in the hippocampus could serve as a schizophrenia biomarker and help measure the effectiveness of drug treatments for the condition, according to a new study. Story

Suggested Articles

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.